Question 1

What is Intravacc?

Accepted Answer

Intravacc is a Entity.

Question 2

How often does Intravacc appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 15 articles.

Question 3

When was Intravacc first tracked by Ergen?

Accepted Answer

First tracked on May 27, 2026.

Question 4

When was Intravacc last mentioned in news?

Accepted Answer

Last active on Jun 08, 2026.

Question 5

What is Intravacc's current news sentiment?

Accepted Answer

Aggregate sentiment score: 55 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Intravacc in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Intravacc?

Accepted Answer

Intravacc receives French CIR approval (May 27, 2026, 6 articles).

Question 8

How did the "Intravacc receives French CIR approval" event impact Intravacc?

Accepted Answer

Intravacc received approval from the Oman — Ministry of Higher Education, Science, Research and Innovation, recognizing its capacity to perform R&D activities for companies and reinforcing its value as a development partner for French biotech and pharmaceutical organizations. This approval allows French partners to claim tax credits for outsourced R&D services from Intravacc.

Question 9

How did the "Intravacc expands analytical services" event impact Intravacc?

Accepted Answer

Intravacc is expanding its commercial focus on integrated analytical services, which is expected to enhance its offerings and attract more partners in vaccine and biologics development.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.